About Molecular Health
Molecular Health is a company based in Heidelberg (Germany) founded in 2004 by Friedrich Von Bohlen. Molecular Health has raised $26.92 million across 1 funding round from investors including dievini. The company has 121 employees as of December 31, 2020. Molecular Health offers products and services including MH Guide CAS, AI Pharma Solutions, and Dataome. Molecular Health operates in a competitive market with competitors including Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.
- Headquarter Heidelberg, Germany
- Employees 121 as on 31 Dec, 2020
- Founders Friedrich Von Bohlen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$790.96 K (USD)184as on Dec 31, 2018
-
Net Profit
$50.3 M (USD)362as on Dec 31, 2019
-
EBITDA
-$50.3 M (USD)-162as on Dec 31, 2019
-
Total Equity Funding
$26.92 M (USD)
in 1 rounds
-
Latest Funding Round
$26.92 M (USD), Private Equity Round
Nov 16, 2015
- Investors
-
Employee Count
121
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Health
Molecular Health offers a comprehensive portfolio of products and services, including MH Guide CAS, AI Pharma Solutions, and Dataome.
Software for annotating genetic tumor data and clinical trials.
Platform providing insights for pharmaceutical data analysis.
Tool for advanced analyses in drug development processes.
People of Molecular Health
Unlock access to complete
Funding Insights of Molecular Health
Molecular Health has successfully raised a total of $26.92M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $26.92 million completed in November 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Molecular Health
Molecular Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include dievini.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in life and health sciences companies.
|
Locked | Locked | Locked |
Investor details for Molecular Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Health
Investment portfolio details for Molecular Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Health
Detailed financials for Molecular Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Health Comparisons
Peer comparison for Molecular Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Health
Molecular Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
Platforms for genomic data analysis and management are provided.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of Molecular Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Health
Complete news archive for Molecular Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Health
Molecular Health was founded in 2004 and raised its 1st funding round 11 years after it was founded.
Molecular Health is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Friedrich Von Bohlen is the current CEO of Molecular Health. They have also founded this company.
Molecular Health is a funded company, having raised a total of $26.92M across 1 funding round to date.
As of Dec 31, 2020, the latest employee count at Molecular Health is 121.
Annual revenue of Molecular Health is $790.96K as on Dec 31, 2018.
Genomic software solutions for healthcare providers. Its proprietary Dataome platform is a SaaS product and is capable of converting both structured and unstructured NGS data into clinically actionable results. The Dataome Knowledgebase contains information for 97k drugs, 54M drug names, 4.6M drug interactions, 85k genomic variants, and 109k clinical trials. Currently, Molecular Health has three products based on its technology. MH Guide Labs converts genetic variant data into a comprehensive tumor profile to enable labs with NGS capabilities. MH Guide Hospitals is an enterprise solution that uses sequencing data to evaluate drug efficacy, drug-drug interactions, and drug-patient compatibility for tailored cancer therapies. MH Effect is a specialized product that predicts drug-drug interactions and drug-induced adverse effects by using patient genomic data.
Molecular Health's top competitors include Eagle Genomics, Depixus and Ingenuity Systems.
Molecular Health offers MH Guide CAS, AI Pharma Solutions, and Dataome.
Molecular Health has 1 investor. Key investors include dievini.